Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q78045320)
Watch
English
Hepatitis B therapy: the plot thickens
scientific article published on 01 August 1999
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10421673
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
title
Hepatitis B therapy: the plot thickens
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10421673
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
main subject
hepatitis B
1 reference
based on heuristic
inferred from title
author name string
Malik AH
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10421673
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
Lee WM
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10421673
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
language of work or name
English
0 references
publication date
1 August 1999
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10421673
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
published in
Hepatology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10421673
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
volume
30
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10421673
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10421673
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
page(s)
579-581
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10421673
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
cites work
Hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The discovery of the hepatitis viruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapy of chronic viral hepatitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term remission of chronic hepatitis B after alpha-interferon therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine resistance inimmunocompetent chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC (3TC) resistance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine for chronic delta hepatitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.510300238
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/HEP.510300238
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10421673
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
PubMed publication ID
10421673
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10421673
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
